Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis
- PMID: 19016656
- DOI: 10.1042/CS20070311
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis
Abstract
NAFLD (non-alcoholic fatty liver disease) encompasses the spectrum of fatty liver disease in insulin-resistant individuals who often display T2DM (Type 2 diabetes mellitus) and obesity. The present review highlights the pathophysiological basis and clinical evidence for a possible causal linkage between NAFLD and CVD (cardiovascular disease). The role of traditional and non-traditional CVD risk factors in the pathophysiology of NAFLD is considered in the first part of the review, with the basic science shared by atherogenesis and hepatic steatogenesis discussed in depth in the second part. In conclusion, NAFLD is not an innocent bystander, but a major player in the development and progression of CVD. NAFLD and CVD also share similar molecular mechanisms and targeted treatment strategies. On the research side, studies should focus on interventions aimed at restoring energy homoeostasis in lipotoxic tissues and at improving hepatic (micro)vascular blood supply.
Similar articles
-
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.Nutr Metab Cardiovasc Dis. 2007 Nov;17(9):684-98. doi: 10.1016/j.numecd.2007.01.007. Epub 2007 Jun 7. Nutr Metab Cardiovasc Dis. 2007. PMID: 17560098 Review.
-
The role of non-alcoholic fatty liver disease in cardiovascular disease.Dig Dis. 2010;28(1):210-3. doi: 10.1159/000282088. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460913 Review.
-
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.Diabet Med. 2007 Jan;24(1):1-6. doi: 10.1111/j.1464-5491.2007.02025.x. Diabet Med. 2007. PMID: 17227317 Review.
-
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.Am J Gastroenterol. 2008 Dec;103(12):3036-8. doi: 10.1111/j.1572-0241.2008.02196.x. Epub 2008 Oct 1. Am J Gastroenterol. 2008. PMID: 18853984
-
Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.J Dig Dis. 2008 May;9(2):63-7. doi: 10.1111/j.1751-2980.2008.00323.x. J Dig Dis. 2008. PMID: 18419637 Review.
Cited by
-
γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.Diabetologia. 2015 Jul;58(7):1484-93. doi: 10.1007/s00125-015-3575-y. Epub 2015 Mar 29. Diabetologia. 2015. PMID: 25820150 Free PMC article.
-
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.Metabolites. 2022 Mar 11;12(3):238. doi: 10.3390/metabo12030238. Metabolites. 2022. PMID: 35323681 Free PMC article. Review.
-
Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.Medicine (Baltimore). 2019 Mar;98(9):e14672. doi: 10.1097/MD.0000000000014672. Medicine (Baltimore). 2019. PMID: 30817593 Free PMC article.
-
Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.Diabetes Care. 2011 Feb;34(2):448-53. doi: 10.2337/dc10-1076. Epub 2011 Jan 7. Diabetes Care. 2011. PMID: 21216854 Free PMC article.
-
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.World J Gastroenterol. 2014 Apr 7;20(13):3410-7. doi: 10.3748/wjg.v20.i13.3410. World J Gastroenterol. 2014. PMID: 24707124 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
